The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
about
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.Global positioning system use in the community to evaluate improvements in walking after revascularization: a prospective multicenter study with 6-month follow-up in patients with peripheral arterial disease.First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.Percutaneous versus surgical management of lower extremity peripheral artery disease.Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.Effectiveness of Viabahn in the Treatment of Superficial Femoral Artery Occlusive Disease: A Systematic Review and Meta-analysis.Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.Superficial Femoral Artery Intervention: Creating an Algorithmic Approach for the Use of Old and Novel (Endovascular) Technologies.The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.Feasibility and 1-Year outcomes of subintimal revascularization with supera® stenting of long femoropopliteal occlusions in critical limb ischemia: The "Supersub" Study.Evaluation of the 4-French Pulsar-18 Self-expanding Nitinol Stent in Long Femoropopliteal Lesions.Early Post-Registry Experience With Drug-Eluting Stents in the Superficial Femoral Artery.[Stent-assisted recanalization of femoropopliteal arterial occlusive disease. Influence of stent design on patency rates].SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system.Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.A call for long-term data in clinical studies of infrainguinal peripheral arterial revascularization: The DURABILITY II Study delivers.Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: Midterm results.Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.Nitinol Stents in the Femoropopliteal Artery: A Mechanical Perspective on Material, Design, and Performance.Nitinol Self-Expanding Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Three-Year Results of the RELIABLE Japanese Multicenter Study
P2860
Q33710114-695002F7-3ACF-4DFC-9FE6-D67C944535B0Q35150908-B15A8DF4-23CC-432C-A7BF-DBF68932132CQ36151340-61D8DB0E-1D7F-4AD2-8993-448C25394A07Q36354843-569CBDFE-05DE-4A99-B5BC-175B61200F18Q38133465-4BF5B731-432E-4F1E-9C0D-3DF8BE0221F4Q38211926-1D3FCAB3-5C37-46F9-BD67-EF7BC37889C5Q38328898-8A71423C-0450-43D4-B6C0-D9A16DD9510CQ38373588-0C350231-E395-4549-B487-F2D53D3012B0Q38392409-FDE068C9-BAC5-48A1-96DA-BDB54A95E97CQ38505073-6FD5AD9C-356B-4D73-9801-58145FFD2426Q38568152-C83FB889-3705-4502-A1A0-7E4850354E71Q38901942-EF6D6AFA-7D5F-4ABC-92F2-8D3FAD6353ECQ38968545-74D29F37-9E94-4E0A-8D2A-842EC16C0A8BQ38975104-1BA61E0E-D4F0-4639-903A-B0F35A2FEC6EQ39167858-B52722DF-81CB-4154-93A0-2775FAB90C90Q39174616-E738DB1B-3388-4645-8F21-FAB35BD90180Q39574216-4276A76E-C637-428B-AA6F-5B0DAF985FBFQ40778613-0D84C3D4-95EC-421B-AEE8-B58BAAA74466Q40932289-42B24554-0161-4D5E-B3DC-D2CA2767A3DFQ46096478-59B49122-7B49-4BB0-90E2-EEE2D2930433Q46611491-71F795D5-0D1B-4396-ADDB-9C4C1655975DQ47396762-DED23656-C4A5-40FE-A92F-09DE3C63AA41Q49231343-04E0E883-EDCB-4A0B-8763-0B29C173FC00Q50961269-3BE9EA66-D548-4A86-A8E3-7DBA65736FF2Q53266195-26BBF20C-05CE-4A04-9928-69E297F253F4Q53311664-45961A1A-3055-4848-9000-41460E717C32Q53432847-9E75CEA5-24F1-4CE2-AA1A-491C3DFEDF27Q55025537-8F997B3D-A6C0-49D4-8C90-44E478236BFAQ58550954-F277D014-CD4A-48AE-BF93-F5EBA8C546F2
P2860
The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The United States StuDy for Ev ...... ent SYstem II (DURABILITY II).
@en
type
label
The United States StuDy for Ev ...... ent SYstem II (DURABILITY II).
@en
prefLabel
The United States StuDy for Ev ...... ent SYstem II (DURABILITY II).
@en
P2093
P1476
The United States StuDy for Ev ...... ent SYstem II (DURABILITY II).
@en
P2093
Christopher W Pollock
Dai Yamanouchi
Dierk Scheinert
Greg A Schultz
Jeffrey A Goldstein
Jon S Matsumura
Krishna J Rocha-Singh
Marc Bosiers
P304
P356
10.1016/J.JVS.2012.12.066
P577
2013-05-02T00:00:00Z